EUVIMEDEUVIMED entdecken
Open Access

Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells

Kellianne M Piell, Anna Vallarta, Ali E Wilt, Bailey L Avila-Valdes, Mary H Sumlut, Navya Goli, Belinda J Petri, Liqing He, Xiang Zhang, Brian F Clem, Carolyn M Klinge

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-08 · 1872 (6) · 168266

DOI: 10.1016/j.bbadis.2026.168266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-08. Verfasst von Kellianne M Piell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Adenosine, Drug Resistance, Neoplasm, Phosphoglycerate Dehydrogenase. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The N-6-methyladenosine (m6A) modification of mRNA regulates transcript abundance in endocrine therapy (ET)-resistant breast cancer (BCa) cells. We reported that m6A reader HNRNPA2B1 decreased miR-145p and miR-424-5p targeting PSAT1 and miR-34b-5p and miR-876-5p targeting PHGDH, thus stimulating the serine synthesis pathway (SSP) in ET-resistant BCa cells. Here we examined m6A regulation of PSAT1 and PHGDH. We report that siMETTL3 increased miR-145-5p, reducing PSAT1, and miR-34b-5p and miR-876-5p, reducing PHGDH, without affecting HNRNPA2B1 or NFkB and decreasing MYC, known to stimulate PSAT1 and PHGDH transcription. In contrast, the METTL3 inhibitor STM2457 increased METTL3, MYC, HNRNPA2B1, NFkB, PSAT1, PHGDH, and serine synthesis, and decreased the miRNAs. These data suggest that reducing METTL3 protein and inhibition of its catalytic activity have different effects on these targets. Selected results were verified in ET-resistant T47D and ZR-75-1 BCa cells. METTL3’s stimulation of translation may play a role in these differences. Indeed, siMETTL3 had no effect on MYC, PHGDH, or PSAT1 pre-mRNA whereas STM2457 increased these pre-mRNAs. Overall, our data support a model for m6A regulation of PHGDH and PSAT1 indirectly through miRNAs that target PHGDH and PSAT1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAdenosineDrug Resistance, NeoplasmPhosphoglycerate DehydrogenaseHumansFemaleMicroRNAsRNA MethylationGene Expression Regulation, NeoplasticCell Line, TumorMethyltransferasesEpitranscriptome

Stichwörter der Autor:innen

Breast cancerEndocrine resistanceMETTL3PHGDHSTM2457m6AmiRNA

Substanzen

MicroRNAsN-methyladenosineAdenosinePhosphoglycerate DehydrogenaseMethyltransferasesMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.
  • Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA; Kentucky IDeA Networks of Biomedical Research Excellence Bioinformatics Core, University of Louisville S…
  • University of Louisville Center for Integrative Environmental Health Sciences (CIEHS), Louisville, KY, USA; Department of Chemistry, University of Louisville College of Arts and Sciences, Louisville, KY, USA.
  • Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA; University of Louisville Center for Integrative Environmental Health Sciences (CIEHS), Louisville, KY, U…

Förderung

  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • US Department of Defense Peer Reviewed Cancer Research Program
  • California Breast Cancer Research Program
  • U.S. Department of Defense
  • National Institute of Environmental Health Sciences
  • University of Minnesota

Zitieren

APA

Piell, K. M., Vallarta, A., Wilt, A. E., Avila-Valdes, B. L., Sumlut, M. H., Goli, N., Petri, B. J., He, L., Zhang, X., Clem, B. F., & Klinge, C. M. (2026). Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(6), 168266. https://doi.org/10.1016/j.bbadis.2026.168266

Vancouver

Piell KM, Vallarta A, Wilt AE, Avila-Valdes BL, Sumlut MH, Goli N, et al. Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(6):168266. doi:10.1016/j.bbadis.2026.168266

BibTeX
@article{Piell2026,
  author = {Piell, Kellianne M and Vallarta, Anna and Wilt, Ali E and Avila-Valdes, Bailey L and Sumlut, Mary H and Goli, Navya and Petri, Belinda J and He, Liqing and Zhang, Xiang and Clem, Brian F and Klinge, Carolyn M},
  title = {Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2026},
  volume = {1872},
  number = {6},
  pages = {168266},
  doi = {10.1016/j.bbadis.2026.168266}
}
Kostenlos starten →